EpiGenesis Pharmaceuticals Overview
- Year Founded
-
1995
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
EpiGenesis Pharmaceuticals General Information
Description
Developer of inhaled respiratory medicines created to improve the health and quality of life in patients with respiratory diseases. The Company's current lead compound, EPI-12323, is a once daily inhaled non-glucocorticoid steroid that targets the inflammatory and airway obstruction cascade in the irritated lung and treats asthma and chronic obstructive pulmonary disease (COPD).
Contact Information
Website
www.epigene.comCorporate Office
- 7 Clarke Drive
- Cranbury, NJ 08512
- United States
Corporate Office
- 7 Clarke Drive
- Cranbury, NJ 08512
- United States
EpiGenesis Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-Jan-2012 | Completed | Out of Business | |||
| 4. Early Stage VC (Series B) | 29-Jun-2007 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 09-Jun-2003 | Completed | Startup | |||
| 2. Seed Round | 01-Feb-1998 | $2.5M | $2.5M | Completed | Startup | |
| 1. Grant | 21-Oct-1997 | $100K | Completed | Startup |
EpiGenesis Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
EpiGenesis Pharmaceuticals Patents
EpiGenesis Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2008296195-A1 | (dheas) inhalation compositions | Inactive | 07-Sep-2007 | ||
| CA-2698683-A1 | Dheas inhalation compositions | Inactive | 07-Sep-2007 | ||
| EP-2197452-A1 | Dheas inhalation compositions | Inactive | 07-Sep-2007 | ||
| EP-2197452-A4 | Dheas inhalation compositions | Inactive | 07-Sep-2007 | ||
| US-20090118249-A1 | Dheas inhalation compositions | Inactive | 07-Sep-2007 | A61K31/704 |
EpiGenesis Pharmaceuticals FAQs
-
When was EpiGenesis Pharmaceuticals founded?
EpiGenesis Pharmaceuticals was founded in 1995.
-
Where is EpiGenesis Pharmaceuticals headquartered?
EpiGenesis Pharmaceuticals is headquartered in Cranbury, NJ.
-
What industry is EpiGenesis Pharmaceuticals in?
EpiGenesis Pharmaceuticals’s primary industry is Drug Delivery.
-
Is EpiGenesis Pharmaceuticals a private or public company?
EpiGenesis Pharmaceuticals is a Private company.
-
What is EpiGenesis Pharmaceuticals’s current revenue?
The current revenue for EpiGenesis Pharmaceuticals is .
-
How much funding has EpiGenesis Pharmaceuticals raised over time?
EpiGenesis Pharmaceuticals has raised $39.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process